Literature DB >> 18297956

Non-neoplastic epithelial disorders of the vulva.

Theodore Xavier O'Connell1, Leena Shankar Nathan, Wendy Ann Satmary, Andrew T Goldstein.   

Abstract

Lichen sclerosus, lichen planus, and lichen simplex chronicus are three of the most common non-neoplastic epithelial disorders of the vulva. Lichen sclerosus is characterized by intense vulvar itching and can affect men and women of all ages, but it manifests most commonly in postmenopausal women. Patients with lichen sclerosus have an increased risk of developing squamous cell carcinoma, and they should be monitored for malignancy. Lichen planus is an inflammatory autoimmune disorder that can affect the vulva and the vagina; it peaks in incidence between ages 30 and 60. There are three clinical variants of lichen planus affecting the vulva: erosive, papulosquamous, and hypertrophic. Lichen simplex chronicus is caused by persistent itching and scratching of the vulvar skin, which results in a thickened, leathery appearance. It is thought to be an atopic disorder in many cases and may arise in normal skin as a result of psychological stress or environmental factors. Definitive diagnosis of non-neoplastic disorders depends on the histology of biopsied tissue. All three disorders are treated with topical corticosteroid ointments of varying potency. Lichen sclerosus and lichen planus are not routinely treated with surgery, which is necessary only in patients who have a malignancy or advanced scarring that causes dyspareunia or clitoral phimosis. Educational counseling teaches patients that even though these chronic disorders cannot be cured, they can be effectively managed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297956

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  9 in total

Review 1.  Vulvar pruritus in a postmenopausal woman.

Authors:  Emily Caro-Bruce; Gabriel Flaxman
Journal:  CMAJ       Date:  2014-02-18       Impact factor: 8.262

2.  Sinecatechins Ointment, 15% for the Treatment of External Genital and Perianal Warts: Proceedings of an Expert Panel Roundtable Meeting.

Authors:  Gary Goldenberg; Maida Taylor; Brian Berman; Mark Kaufmann; William Abramovits; Joshua Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2016-03-01

3.  Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD.

Authors:  B Frey Tirri; P Häusermann; H Bertz; H Greinix; A Lawitschka; C-P Schwarze; D Wolff; J P Halter; D Dörfler; R Moffat
Journal:  Bone Marrow Transplant       Date:  2014-10-27       Impact factor: 5.483

Review 4.  Vulvovaginal atrophy.

Authors:  Maire B Mac Bride; Deborah J Rhodes; Lynne T Shuster
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

5.  Physician-administered clinical score of vulvar lichen sclerosus: A study of 36 cases.

Authors:  Smriti Naswa; Yogesh S Marfatia
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jul-Dec

6.  Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen Sclerosus.

Authors:  Fariba Behnia-Willison; Nina Reza Pour; Behrang Mohamadi; Nadia Willison; Madeleine Rock; Ian W Holten; Robert O'Shea; Joseph Miller
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-11-23

Review 7.  Lichenoid vulvar disease: A review.

Authors:  R Fruchter; L Melnick; M K Pomeranz
Journal:  Int J Womens Dermatol       Date:  2017-03-27

8.  Study of pruritus vulvae in geriatric age group in tertiary hospital.

Authors:  Jasleen Kaur; Jyotika Kalsy
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jan-Jun

Review 9.  New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review.

Authors:  Vittoria Benini; Alessandro Ferdinando Ruffolo; Arianna Casiraghi; Rebecca S Degliuomini; Matteo Frigerio; Andrea Braga; Maurizio Serati; Marco Torella; Massimo Candiani; Stefano Salvatore
Journal:  Medicina (Kaunas)       Date:  2022-06-06       Impact factor: 2.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.